Vor Biopharma (VOR) Cash from Operations (2020 - 2026)
Vor Biopharma (VOR) reported Cash from Operations of 38246000.0 for Q1 2026, down 23.11% year-over-year from 49742536.88 in Q1 2025, and down 67.74% quarter-over-quarter from 22801000.0 in Q4 2025.
Vor Biopharma (VOR) Cash from Operations (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Cash from Operations data on file, last reported at 38246000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 38246000.0, down 23.11% year-over-year; the trailing twelve-month figure through Mar 2026 was 149893000.0 (down 49.5% YoY), and the FY2025 annual result was 142713000.0, down 43.2% from the prior year.
- Cash from Operations fell to 38246000.0 in Q1 2026 per VOR's latest filing, from 22801000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 18346000.0 in Q4 2022 and troughed at 53662000.0 in Q3 2025.
- A 5-year average of 27415000.0 and a median of 24100000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations increased 16.54% in 2024, then plunged 130.46% in 2025.
- A 5-year view of Cash from Operations shows it stood at 18346000.0 in 2022, then slumped by 30.96% to 24026000.0 in 2023, then slipped by 0.15% to 24063000.0 in 2024, then advanced by 5.24% to 22801000.0 in 2025, then sank by 67.74% to 38246000.0 in 2026.
- Business Quant data shows VOR's Cash from Operations at 38246000.0 in Q1 2026, 22801000.0 in Q4 2025, and 53662000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vor Biopharma | 627.54 Mn | 627.54 Mn | - | -38.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.25 Mn |
| Mar 31, 2026 | -38.25 Mn |
| Dec 31, 2025 | -22.80 Mn |
| Dec 31, 2025 | -22.80 Mn |
| Sep 30, 2025 | -53.66 Mn |
| Sep 30, 2025 | -53.66 Mn |
| Jun 30, 2025 | -35.18 Mn |
| Jun 30, 2025 | -35.18 Mn |
| Mar 31, 2025 | -31.07 Mn |
| Mar 31, 2025 | -31.07 Mn |
| Dec 31, 2024 | -24.06 Mn |
| Dec 31, 2024 | -24.06 Mn |
| Sep 30, 2024 | -23.29 Mn |
| Sep 30, 2024 | -23.29 Mn |
| Jun 30, 2024 | -21.85 Mn |
| Jun 30, 2024 | -21.85 Mn |
| Mar 31, 2024 | -30.47 Mn |
| Mar 31, 2024 | -30.47 Mn |
| Dec 31, 2023 | -24.03 Mn |
| Dec 31, 2023 | -24.03 Mn |